UNSPSC 51431700: Antihypertensive benzazepines

Antihypertensive drugs made from compounds with benzene fused to azepines.

UNSPSC 51431700 Antihypertensive benzazepines is a Class code covering medications used in emergency medical response and state health agency procurement, specifically antihypertensive agents supplied to fire rescue services, hospital systems, and state pharmacy benefit programs. State and local governments buy these medications primarily through city purchasing departments managing emergency medical supplies, state health agencies coordinating pharmacy benefits for employee and Medicaid populations, and cooperative purchasing alliances aggregating demand across multiple jurisdictions. The work involves supplying finished pharmaceutical products with specific National Drug Codes (NDCs), managing expiration dates and shelf-life compliance, arranging logistics and delivery within defined timeframes, providing Safety Data Sheets compliant with OSHA Hazard Communication Standards, and maintaining manufacturing certifications including current Good Manufacturing Practices (cGMP) and Drug Supply Chain Security Act (DSCSA) compliance. Issuing bodies include municipal purchasing departments (cities), state health and human services agencies, and multistate cooperative purchasing organizations serving both state and local facilities. Recent solicitations show activity across fire rescue procurement, state Medicaid pharmacy management, and cooperative purchasing networks.

Geographic activity spans Florida, Texas, and Minnesota with multistate reach through cooperative purchasing vehicles. The City of Tampa's Purchasing Department issued IFB 26P00188 in April 2026 for Advanced Life Support Medications including Labetalol, Epinephrine, Adenosine, and Diltiazem vials for Tampa Fire Rescue, with a due date of April 8, 2026 and estimated contract value of $40,000.00; the award carries a one-year initial term with two one-year renewal options and unilateral extension rights for up to three additional 30-day periods, with a 5 percent bid discount available for Small Local Business Enterprise participation. The Texas Health and Human Services Commission issued RFI HHS0017013 in April 2026 to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, seeking information about direct contracting outside traditional pharmacy benefit manager arrangements. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued RFP S1070000015802 with a response deadline of March 26, 2026 for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities in Minnesota and Oregon, with contract effectiveness July 1, 2026 and a two-year initial term.